← Back to All US Stocks

CFOR Stock Analysis - CapForce Inc. AI Rating

CFOR OTC Services-Medical Laboratories DE CIK: 0001293818
Recently Updated • Analysis: Mar 22, 2026 • SEC Data: 2025-09-30
AI Rating
SELL
85% Confidence

📊 CFOR Key Takeaways

Revenue: $4.0M
Net Margin: 62.3%
Free Cash Flow: $-1.8M
Current Ratio: 7.06x
Debt/Equity: 0.91x
EPS: $0.24
AI Rating: SELL with 85% confidence

Investment Thesis

CapForce demonstrates exceptional profitability metrics with 62.3% net margins and strong returns on equity (24.5%), but these gains are severely undermined by negative free cash flow of -$1.8M despite positive net income of $2.5M, indicating potential accounting quality issues or unsustainable capital structures. The company's high leverage (0.91x debt/equity) combined with deteriorating cash generation and minimal insider confidence (zero Form 4 filings in 90 days) raises red flags about the sustainability of reported earnings.

CFOR Strengths

  • + Exceptional net profit margin of 62.3% with revenue growth of 52% YoY
  • + Strong liquidity position with 7.06x current ratio and minimal cash requirements
  • + Excellent return metrics: 24.5% ROE and 19.7% ROA indicate efficient capital deployment
  • + Outstanding operating margin of 54.4% suggests pricing power and operational efficiency

CFOR Risks

  • ! Severe cash flow deterioration: negative $1.8M free cash flow contradicts $2.5M net income, indicating potential earnings quality concerns
  • ! Significant long-term debt of $9.2M (0.91x debt/equity) with only $414.2K cash on hand creates refinancing risk
  • ! Operating cash flow is deeply negative at -$978.7K, suggesting cash is being consumed rather than generated by operations
  • ! Zero insider Form 4 filings in 90 days indicates lack of insider confidence despite reported strong earnings
  • ! Capital expenditure of $800.4K against negative operating cash flow suggests unsustainable investment levels

Key Metrics to Watch

CFOR Financial Metrics

Revenue
$4.0M
Net Income
$2.5M
EPS (Diluted)
$0.24
Free Cash Flow
$-1.8M
Total Assets
$12.6M
Cash Position
$414.2K

💡 AI Analyst Insight

Strong liquidity with a 7.06x current ratio provides a solid financial cushion.

CFOR Profitability Ratios

Gross Margin 23.1%
Operating Margin 54.4%
Net Margin 62.3%
ROE 24.5%
ROA 19.7%
FCF Margin -44.5%

CFOR vs Healthcare Sector

How CapForce Inc. compares to Healthcare sector averages

Net Margin
CFOR 62.3%
vs
Sector Avg 12.0%
CFOR Sector
ROE
CFOR 24.5%
vs
Sector Avg 15.0%
CFOR Sector
Current Ratio
CFOR 7.1x
vs
Sector Avg 2.0x
CFOR Sector
Debt/Equity
CFOR 0.9x
vs
Sector Avg 0.6x
CFOR Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CFOR Balance Sheet & Liquidity

Current Ratio
7.06x
Quick Ratio
3.47x
Debt/Equity
0.91x
Debt/Assets
19.6%
Interest Coverage
248.12x
Long-term Debt
$9.2M

CFOR 5-Year Financial Trend

CFOR 5-year financial data: Year 2018: Revenue $3.2M, Net Income N/A, EPS N/A. Year 2019: Revenue $3.5M, Net Income N/A, EPS N/A. Year 2020: Revenue $4.2M, Net Income -$12.4M, EPS N/A. Year 2021: Revenue $4.3M, Net Income -$26.2M, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: CapForce Inc.'s revenue has grown significantly by 34% over the 5-year period, indicating strong business expansion. The most recent EPS of $-41.47 indicates the company is currently unprofitable.

CFOR Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-44.5%
Free cash flow / Revenue

CFOR Quarterly Performance

Quarterly financial performance data for CapForce Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $196.1K -$608.7K $-0.06
Q2 2025 $28.0K -$1.3M $0.30
Q1 2025 $168.1K $288.0K $-0.04
Q3 2024 $196.1K -$4.1M $1.35
Q2 2024 $28.0K $288.0K N/A
Q1 2024 $168.1K $386.0K $0.21
Q3 2023 $448.7K -$4.1M $-0.46
Q2 2023 $736.1K -$5.8M $-0.93

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

CFOR Capital Allocation

Operating Cash Flow
-$978.7K
Cash generated from operations
Capital Expenditures
$800.4K
Investment in assets
Dividends
None
No dividend program

CFOR SEC Filings

Access official SEC EDGAR filings for CapForce Inc. (CIK: 0001293818)

📋 Recent SEC Filings

Date Form Document Action
Feb 27, 2026 8-K capforceinc_8k.htm View →
Feb 6, 2026 DEF 14A opgen_def14a.htm View →
Jan 16, 2026 8-K opgeninc_8k.htm View →
Dec 23, 2025 8-K opgeninc_8k.htm View →
Dec 5, 2025 8-K opgeninc_8k.htm View →

Frequently Asked Questions about CFOR

What is the AI rating for CFOR?

CapForce Inc. (CFOR) has an AI rating of SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CFOR's key strengths?

Exceptional net profit margin of 62.3% with revenue growth of 52% YoY. Strong liquidity position with 7.06x current ratio and minimal cash requirements.

What are the risks of investing in CFOR?

Severe cash flow deterioration: negative $1.8M free cash flow contradicts $2.5M net income, indicating potential earnings quality concerns. Significant long-term debt of $9.2M (0.91x debt/equity) with only $414.2K cash on hand creates refinancing risk.

What is CFOR's revenue and growth?

CapForce Inc. reported revenue of $4.0M.

Does CFOR pay dividends?

CapForce Inc. does not currently pay dividends.

Where can I find CFOR SEC filings?

Official SEC filings for CapForce Inc. (CIK: 0001293818) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CFOR's EPS?

CapForce Inc. has a diluted EPS of $0.24.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 22, 2026 | Data as of: 2025-09-30 | Powered by Claude AI